Exploring new approaches in cancer treatment.
Official title: Clinical Trial Concept in the Oncology Landscape
Funded at Ohio State University · NIH-10766586 · Data updated 2026-11-12
This study is all about making cancer clinical trials better and more helpful for patients by involving them in the design process and working together with different cancer centers to improve results.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ohio State University NIH-funded |
| Lab location | 1 site (Columbus, UNITED STATES) |
| Project start | September 4, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $315,143 |
| NIH project number | 1R25CA278725-01A1 |
| Project ID | NIH-10766586 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation are individuals diagnosed with various types of cancer who are seeking new treatment options.
✕Less likely to help
Patients with non-cancerous conditions or those not currently undergoing cancer treatment may not benefit from this research.
What this research studies
This research focuses on developing innovative concepts in the oncology landscape, particularly through clinical trials. It aims to evaluate and refine methodologies for conducting cancer-related clinical trials, ensuring they are more effective and patient-centered. By involving patients in the trial design process, the research seeks to enhance the relevance and applicability of findings to real-world scenarios. The project will also explore collaborations among various cancer institutes to improve trial outcomes.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments and improved patient outcomes.
How similar studies have gone: Previous research in oncology has shown that innovative trial designs can significantly improve treatment efficacy and patient engagement.
Where this research is happening
-
Ohio State University
Columbus, United States Active
Researchers
- Principal investigator: Verschraegen, Claire F. — Ohio State University
- Study coordinator: Verschraegen, Claire F.
Related research
Other NIH-funded projects on the same topics.
-
Understanding how trinucleotide repeat expansions cause disease
A research project at Ohio State University is exploring how tiny DNA repeats become unstable and drive neurological and muscular diseases, with potential implications for future therapies.
-
Pediatric Prehospital Airway Resuscitation for Critically Ill Children
This grant tests the best way for paramedics to manage breathing tubes and other airways in seriously ill children before they reach the hospital.
-
From Social Breakups to Brain Changes in Alzheimer’s and Related Dementias
This grant explores how losing social connections may trigger brain changes and inflammation linked to Alzheimer’s disease and related dementias.
-
Understanding why patients with blood cancers start and stick with oral cancer medicines
A study to learn what helps or hinders Black patients with blood cancers in starting and continuing their prescribed oral cancer medicines.
-
How sex and hormones affect alcohol's impact on sleep in adults
This study tests how sex and hormone changes influence how alcohol disrupts sleep in healthy adults, with a focus on women aged 21-45.
-
Natural products to block IL-8 signaling and prevent Barrett's Esophagus from turning into esophageal cancer
A搜索-friendly plan to use safe natural compounds to interrupt a key inflammatory signal (IL-8) and stop Barrett’s esophagus from turning into esophageal cancer in people with GERD.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.